Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 326

2.

Technological advances in radiotherapy for the treatment of localised prostate cancer.

Mangar SA, Huddart RA, Parker CC, Dearnaley DP, Khoo VS, Horwich A.

Eur J Cancer. 2005 Apr;41(6):908-21. Review.

PMID:
15808957
3.
4.

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.

Martinez AA, Demanes DJ, Galalae R, Vargas C, Bertermann H, Rodriguez R, Gustafson G, Altieri G, Gonzalez J.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1322-31.

PMID:
16029788
5.

Intensity-modulated radiation therapy for prostate cancer.

Jani AB, Roeske JC, Rash C.

Clin Prostate Cancer. 2003 Sep;2(2):98-105. Review.

PMID:
15040870
6.

A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.

Hermesse J, Biver S, Jansen N, Lenaerts E, De Patoul N, Vynckier S, Coucke P, Scalliet P, Nickers P.

Strahlenther Onkol. 2009 Nov;185(11):736-42. doi: 10.1007/s00066-009-2009-5.

PMID:
19899007
7.

Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer.

Zaider M, Zelefsky MJ, Cohen GN, Chui CS, Yorke ED, Ben-Porat L, Happersett L.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):702-13.

PMID:
15708248
8.

Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.

King CR, DiPetrillo TA, Wazer DE.

Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):165-72.

PMID:
10656389
9.

Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer.

Tao Y, Lefkopoulos D, Ibrahima D, Bridier A, Polizzi Mdel P, Wibault P, De Crevoisier R, Arriagada R, Bourhis J.

Acta Oncol. 2008;47(3):442-50.

PMID:
17906985
10.

Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer.

Leibel SA, Fuks Z, Zelefsky MJ, Hunt M, Burman CM, Mageras GS, Chui CS, Jackson A, Amols HI, Ling CC.

Semin Oncol. 2003 Oct;30(5):596-615. Review.

PMID:
14571409
11.

Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy.

Welsh JS, Berta C, Borzillary S, Sam C, Shickell D, Nobile L, Greenberg M, Weiss S, Detorie N.

Technol Cancer Res Treat. 2004 Aug;3(4):359-64.

PMID:
15270586
13.

Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.

Koontz BF, Chino J, Lee WR, Hahn CA, Buckley N, Huang S, Kim J, Reagan R, Joyner R, Anscher MS.

Brachytherapy. 2009 Apr-Jun;8(2):191-6. doi: 10.1016/j.brachy.2009.01.002.

PMID:
19433320
14.

Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy.

Al-Salihi O, Mitra A, Payne H.

Prostate Cancer Prostatic Dis. 2006;9(4):370-3. Review.

PMID:
16832383
15.

Three-dimensional conformal brachytherapy for prostate cancer.

Zelefsky MJ.

Curr Urol Rep. 2004 Jun;5(3):173-8. Review.

PMID:
15161565
16.

Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.

Zelefsky MJ, Nedelka MA, Arican ZL, Yamada Y, Cohen GN, Shippy AM, Park JJ, Zaider M.

Brachytherapy. 2008 Jan-Mar;7(1):1-6. doi: 10.1016/j.brachy.2007.12.002.

PMID:
18299108
17.

Technology Insight: Combined external-beam radiation therapy and brachytherapy in the management of prostate cancer.

Hurwitz MD.

Nat Clin Pract Oncol. 2008 Nov;5(11):668-76. doi: 10.1038/ncponc1224. Review.

PMID:
18825143
18.

Combined external beam radiotherapy and Pd-103 brachytherapy boost improves biochemical failure free survival in patients with clinically localized prostate cancer: results of a matched pair analysis.

Singh AM, Gagnon G, Collins B, Niroomand-Rad A, McRae D, Zhang Y, Regan J, Lynch J, Dritschilo A.

Prostate. 2005 Jan 1;62(1):54-60.

PMID:
15389809
19.

High dose rate brachytherapy in the treatment of prostate cancer.

Vicini F, Vargas C, Gustafson G, Edmundson G, Martinez A.

World J Urol. 2003 Sep;21(4):220-8. Review.

PMID:
12905008
20.

Recent advances in light ion radiation therapy.

Brahme A.

Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):603-16. Review.

PMID:
14751534
Items per page

Supplemental Content

Support Center